P

Peijia Medical Ltd
HKEX:9996

Watchlist Manager
Peijia Medical Ltd
HKEX:9996
Watchlist
Price: 3.88 HKD 0.52% Market Closed
Market Cap: 2.5B HKD
Have any thoughts about
Peijia Medical Ltd?
Write Note

Peijia Medical Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Peijia Medical Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
P
Peijia Medical Ltd
HKEX:9996
Cash & Cash Equivalents
ÂĄ795.8m
CAGR 3-Years
-31%
CAGR 5-Years
53%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Cash & Cash Equivalents
ÂĄ1.3B
CAGR 3-Years
120%
CAGR 5-Years
70%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cash & Cash Equivalents
ÂĄ6.5B
CAGR 3-Years
35%
CAGR 5-Years
57%
CAGR 10-Years
36%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cash & Cash Equivalents
ÂĄ20.5B
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Cash & Cash Equivalents
ÂĄ1.7B
CAGR 3-Years
-11%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cash & Cash Equivalents
ÂĄ7.5B
CAGR 3-Years
34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Peijia Medical Ltd
Glance View

Market Cap
2.6B HKD
Industry
Health Care

Peijia Medical Ltd. engages in the manufacture and sale of medical devices. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2020-05-15. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and development of neurointerventional procedural medical devices. The firm's main products under development include TaurusOne, TaurusElite, TaurusNXT and others. The firm operates its businesses primarily in domestic market.

Intrinsic Value
5.28 HKD
Undervaluation 27%
Intrinsic Value
Price
P

See Also

What is Peijia Medical Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
795.8m CNY

Based on the financial report for Dec 31, 2023, Peijia Medical Ltd's Cash & Cash Equivalents amounts to 795.8m CNY.

What is Peijia Medical Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
53%

Over the last year, the Cash & Cash Equivalents growth was -52%. The average annual Cash & Cash Equivalents growth rates for Peijia Medical Ltd have been -31% over the past three years , 53% over the past five years .

Back to Top